Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 23582602)

1.

Identification of the c-kit gene mutations in biopsy tissues of mammary gland carcinoma tumor.

Hussain SR, Naqvi H, Ahmed F, Babu SG, Bansal C, Mahdi F.

J Egypt Natl Canc Inst. 2012 Jun;24(2):97-103. doi: 10.1016/j.jnci.2011.10.003. Epub 2011 Nov 9.

2.

Molecular characterization of piebaldism in a Tunisian family.

Kerkeni E, Boubaker S, Sfar S, Bizid M, Besbes H, Bouaziz S, Ghedira N, Amara A, Manoubi W, Gribaa M, Monastiri K.

Pathol Biol (Paris). 2015 Jun;63(3):113-6. doi: 10.1016/j.patbio.2015.03.004. Epub 2015 Apr 21.

PMID:
25910686
3.

Genetic profiling of thymic carcinoma using targeted next-generation sequencing.

Shitara M, Okuda K, Suzuki A, Tatematsu T, Hikosaka Y, Moriyama S, Sasaki H, Fujii Y, Yano M.

Lung Cancer. 2014 Nov;86(2):174-9. doi: 10.1016/j.lungcan.2014.08.020. Epub 2014 Sep 10.

PMID:
25249426
4.

The Frequency of Mutations in Exon 11 of the c-kit Gene in Patients With Leukemia.

Hussain SR, Babu SG, Naqvi H, Singh P, Mahdi F.

Turk J Haematol. 2012 Mar;29(1):10-6. doi: 10.5505/tjh.2012.60320. Epub 2012 Mar 15.

5.

Somatic mutation of KIT is rare in small cell lung cancer patients from Northeast China.

Xuan H, Jingshu G, Fang Y, Na L, Xiaolin S, Zhaoyang Y, Meng W, Gongyan C.

Histol Histopathol. 2014 Feb;29(2):273-8. Epub 2013 Aug 16.

PMID:
23965952
6.

Heterogeneity of internal tandem duplications in the c-kit of dogs with multiple mast cell tumours.

Amagai Y, Tanaka A, Matsuda A, Jung K, Oida K, Nishikawa S, Jang H, Matsuda H.

J Small Anim Pract. 2013 Jul;54(7):377-80. doi: 10.1111/jsap.12069. Epub 2013 Apr 25.

PMID:
23614673
7.

Extracellular domain c-kit mutation with duplication of Ser501Ala502 found in gastrointestinal stromal tumors is more imatinib- and nilotinib-sensitive than that with duplication of Ala502Tyr503.

Liu NN, Ohkouchi M, Hashikura Y, Kajimoto N, Matsuda I, Isozaki K, Toh Y, Takahashi T, Nishida T, Hirota S.

Lab Invest. 2013 May;93(5):502-7. doi: 10.1038/labinvest.2013.43. Epub 2013 Mar 4.

8.

[C-kit, NPM1 and FLT3 gene mutation patterns and their prognostic significance in 656 Chinese patients with acute myeloid leukemia].

Ding ZX, Shen HJ, Miao JC, Chen SN, Qiu QC, Qi XF, Jin ZM, Wu DP, He J.

Zhonghua Xue Ye Xue Za Zhi. 2012 Oct;33(10):829-34. Chinese.

9.

C-kit expression of melanocytic neoplasm and association with clinicopathological parameters and anatomic locations in Chinese people.

Lin YC, Chang YM, Ho JY, Lin HC, Tsai YM, Chiang CP, Wang WM, Gao HW.

Am J Dermatopathol. 2013 Jul;35(5):569-75. doi: 10.1097/DAD.0b013e318279566a.

PMID:
23221472
10.

Spectrum of mutations in gastrointestinal stromal tumor patients - a population-based study from Slovakia.

Minárik G, Plank L, Lasabová Z, Szemes T, Burjanivová T, Szépe P, Buzalková V, Porubský D, Sufliarsky J.

APMIS. 2013 Jun;121(6):539-48. doi: 10.1111/apm.12019. Epub 2012 Oct 27.

PMID:
23106360
11.

[Secondary mutation of c-kit/PDGFRα genotypes after imatinib mesylate therapy and its relationship with efficacy of sunitinib].

Hong JL, Li J, Li J, Shen L.

Zhonghua Bing Li Xue Za Zhi. 2012 Jun;41(6):386-90. doi: 10.3760/cma.j.issn.0529-5807.2012.06.006. Chinese.

PMID:
22932406
12.

Tyrosine-kinase mutations in c-KIT and PDGFR-alpha genes of imatinib naïve adult patients with gastrointestinal stromal tumours (GISTs) of the stomach and small intestine: relation to tumour-biological risk-profile and long-term outcome.

Søreide K, Sandvik OM, Søreide JA, Gudlaugsson E, Mangseth K, Haugland HK.

Clin Transl Oncol. 2012 Aug;14(8):619-29. doi: 10.1007/s12094-012-0851-x. Epub 2012 Jul 18.

PMID:
22855146
13.

KIT proto-oncogene exon 8 deletions at codon 419 are highly frequent in acute myeloid leukaemia with inv(16) in Indian population.

Hussain SR, Naqvi H, Mahdi F, Bansal C, Babu SG.

Mol Biotechnol. 2013 Jun;54(2):461-8. doi: 10.1007/s12033-012-9584-x.

PMID:
22825855
14.

C-KIT mutations were closely associated with the response to Imatinib in Chinese advanced gastrointestinal stromal tumor patients.

Gao J, Dang Y, Sun N, Li J, Shen L.

Med Oncol. 2012 Dec;29(5):3039-45. doi: 10.1007/s12032-012-0308-7. Epub 2012 Jul 20.

PMID:
22815156
15.

Screening of the c-kit gene missense mutation in invasive ductal carcinoma of breast among north Indian population.

Hussain SR, Babu SG, Raza ST, Singh P, Ahmed F, Naqvi H, Mahdi F.

Mol Biol Rep. 2012 Sep;39(9):9139-44. doi: 10.1007/s11033-012-1786-6. Epub 2012 Jun 24.

PMID:
22729910
17.

[Analysis of tyrosine kinases gene mutations in core binding factor related acute myeloid leukemia and its clinical significance].

Qiao M, Li WY, Sun AN, Chen SN, Liang JY, Ding ZX, Feng YF, Wu DP.

Zhonghua Xue Ye Xue Za Zhi. 2011 Oct;32(10):679-83. Chinese.

18.

[PIK3CA mutation is an independent indicator of malignant phenotype and prognosis in breast cancer].

Li SY, Wang W, Li JM, Wang Z, Wen RY, Chen J, Miao XT.

Zhonghua Zhong Liu Za Zhi. 2011 Aug;33(8):605-8. Chinese.

PMID:
22325221
19.

Mast cell leukemia: identification of a new c-Kit mutation, dup(501-502), and response to masitinib, a c-Kit tyrosine kinase inhibitor.

Georgin-Lavialle S, Lhermitte L, Suarez F, Yang Y, Letard S, Hanssens K, Feger F, Renand A, Brouze C, Canioni D, Asnafi V, Chandesris MO, Aouba A, Gineste P, Macintyre E, Mansfield CD, Moussy A, Lepelletier Y, Dubreuil P, Hermine O.

Eur J Haematol. 2012 Jul;89(1):47-52. doi: 10.1111/j.1600-0609.2012.01761.x. Epub 2012 Apr 28.

PMID:
22324351
20.

High KIT and PDGFRA are associated with shorter patients survival in gastroenteropancreatic neuroendocrine tumors, but mutations are a rare event.

Knösel T, Chen Y, Altendorf-Hofmann A, Danielczok C, Freesmeyer M, Settmacher U, Wurst C, Schulz S, Yang LL, Petersen I.

J Cancer Res Clin Oncol. 2012 Mar;138(3):397-403. doi: 10.1007/s00432-011-1107-9. Epub 2011 Dec 8.

PMID:
22160160
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk